Reported segment mix · SEC DERA dimensional facts

RCM TECHNOLOGIES, INC. RCMT revenue by segment, product and geography

In its fiscal year ending 2025-12-31, RCM TECHNOLOGIES, INC. reported revenue across 4 business segments; the largest, Specialty Health Care, was $164M, 51.4% of the filed sum (+15.0% against the prior period in the same filing).

Full financial analysis →Company overview →

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing

Fiscal year ending 2025-12-3110-K filed 2026-04-03prior period 2024-12-31 from the same filingView filing

By business segment

Revenue

Specialty Health Care$164M
51.4%
+15.0% yoy
Engineering$120M
37.7%
+24.9% yoy
Life Sciences Data Solutions$34.8M
10.9%
-11.3% yoy
Corporate$0
0.0%
no prior

Members sum to the consolidated $319M for this period.

Operating income

Specialty Health Care$22.8M
90.8%
+14.3% yoy
Corporate-$18.6M
-74.3%
+13.5% yoy
Engineering$14.6M
58.3%
+45.5% yoy
Life Sciences Data Solutions$6.32M
25.2%
-27.8% yoy

Members sum to the consolidated $25.1M for this period.

By product or service

Revenue

Health Care$164M
51.1%
+15.0% yoy
Engineering Services$120M
37.5%
+24.9% yoy
Technology Service$34.8M
10.8%
-11.3% yoy
Service$1.7M
0.5%
0.0% yoy

Members sum to the consolidated $319M for this period.

By geography

Revenue

United States$290M
90.9%
+13.0% yoy
Europe$15.3M
4.8%
+106.8% yoy
Canada$7.54M
2.4%
+4.7% yoy
PR$6.36M
2.0%
-9.3% yoy

Members sum to the consolidated $319M for this period.

Latest quarter

Quarter ending 2026-03-3110-Q filed 2026-05-14prior period 2025-03-31 from the same filingView filing

Specialty Health Care$48.1M
57.9%
+11.1% yoy
Engineering$26.1M
31.5%
-18.7% yoy
Life Sciences Data Solutions$8.8M
10.6%
-2.8% yoy
Corporate$0
0.0%
no prior

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

About these figures

Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.

Descriptive and educational; not investment advice. Methodology and data lineage.